{"id":84848,"date":"2025-09-08T11:33:56","date_gmt":"2025-09-08T16:33:56","guid":{"rendered":"https:\/\/www.erdheim-chester.org\/onderwerp-diabetes-insipidus-di-beheren\/"},"modified":"2025-09-18T14:17:17","modified_gmt":"2025-09-18T19:17:17","slug":"onderwerp-diabetes-insipidus-di-beheren","status":"publish","type":"post","link":"https:\/\/www.erdheim-chester.org\/nl\/onderwerp-diabetes-insipidus-di-beheren\/","title":{"rendered":"Diabetes insipidus (DI) beheren"},"content":{"rendered":"<p><iframe loading=\"lazy\" title=\"Managing Diabetes Insipidus (AVP-D): Practical Guidance from a Patient-Expert\" width=\"1080\" height=\"608\" src=\"https:\/\/www.youtube.com\/embed\/qash_2MFo1Q?feature=oembed\"  allow=\"accelerometer; autoplay; clipboard-write; encrypted-media; gyroscope; picture-in-picture; web-share\" referrerpolicy=\"strict-origin-when-cross-origin\" allowfullscreen><\/iframe><\/p>\n<p>Pat Gildroy, hoofdbeheerder van de Facebook-groep &#8220;Got Arginine VasoPressin Deficiency?&#8221; over de bronnen, symptomen, tests en de ervaringen van pati\u00ebnten die leven met Arginine Vasopressin Deficiency, voorheen bekend als Diabetes Insipidus.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Het omgaan met Diabetes Insipidus (DI), tegenwoordig Arginine Vasopressine Defici\u00ebntie (AVP-D) genoemd, is van cruciaal belang voor pati\u00ebnten, families en artsen &#8211; vooral voor pati\u00ebnten met Erdheim-Chester Disease (ECD) of Langerhans Cell Histiocytosis (LCH), waar AVP-D vaker voorkomt.<\/p>\n","protected":false},"author":20,"featured_media":92895,"comment_status":"open","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_wds_title":"","_wds_metadesc":"","_wds_focus-keywords":"","_wds_meta-robots-adv":"","_wds_meta-robots-noindex":false,"_wds_meta-robots-nofollow":false,"_wds_meta-robots-index":false,"_wds_meta-robots-follow":false,"_wds_autolinks-exclude":false,"_wds_canonical":"","_wds_redirect":"","_wds_opengraph":[],"_wds_twitter":{"disabled":true},"cybocfi_hide_featured_image":"","wds_primary_category":0,"footnotes":"","_links_to":"","_links_to_target":""},"categories":[593],"tags":[4779,4782,500,473,1164,4781,4292,4294,2478,4293,4291,4284,2378,4288,4290],"class_list":["post-84848","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-webinar-opnames","tag-diabetes-nl","tag-diabetesinsipidus-nl","tag-ecdga-nl","tag-erdheimchesterdisease-nl","tag-histiocytose-nl","tag-insipidus-nl","tag-klinische-vertaling","tag-medischinnovatie","tag-medischonderzoek","tag-oncologieonderzoek","tag-patientenregister-nl","tag-subsidiekans","tag-wereldgezondheid","tag-wetenschappelijke-samenwerking","tag-zeldzameziektenonderzoek"],"_links":{"self":[{"href":"https:\/\/www.erdheim-chester.org\/nl\/wp-json\/wp\/v2\/posts\/84848","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erdheim-chester.org\/nl\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.erdheim-chester.org\/nl\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/nl\/wp-json\/wp\/v2\/users\/20"}],"replies":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/nl\/wp-json\/wp\/v2\/comments?post=84848"}],"version-history":[{"count":0,"href":"https:\/\/www.erdheim-chester.org\/nl\/wp-json\/wp\/v2\/posts\/84848\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/nl\/wp-json\/wp\/v2\/media\/92895"}],"wp:attachment":[{"href":"https:\/\/www.erdheim-chester.org\/nl\/wp-json\/wp\/v2\/media?parent=84848"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/nl\/wp-json\/wp\/v2\/categories?post=84848"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/nl\/wp-json\/wp\/v2\/tags?post=84848"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}